Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cunningham

Showing results (381-390 of 393) with videos related to

Pageof 40
Sort By:
BMC Infectious Diseases|February 21, 2014
A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern TanzaniaElizabeth A Reddy, Boniface N Njau, Susan C Morpeth, et al.
The Journal of Infectious Diseases|June 22, 2022
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative ChildrenColeen K Cunningham, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases|November 5, 2019
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K Cunningham, Elizabeth J McFarland, R Leavitt Morrison, et al.
Journal of the Pediatric Infectious Diseases Society|January 17, 2025
Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07-523LS in Newborn Infants Exposed to HIV-1Coleen K Cunningham, Elizabeth J McFarland, Petronella Muresan, et al.
The ISME Journal|September 13, 2021
Non-diphtheriae Corynebacterium species are associated with decreased risk of pneumococcal colonization during infancyMatthew S Kelly, Catherine Plunkett, Yahe Yu, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 13, 2022
Academic Health Centers and Humanitarian Crises: One Health System's Response to Unaccompanied Children at the BorderSherin U Devaskar, Coleen K Cunningham, Robin H Steinhorn, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling studyChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Plos One|March 19, 2025
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdensChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Journal of the Pediatric Infectious Diseases Society|August 26, 2020
A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in ChildrenAndi L Shane, Alice I Sato, Carol Kao, et al.
The Journal of Infectious Diseases|August 30, 2014
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responsesGenevieve G Fouda, Coleen K Cunningham, Elizabeth J McFarland, et al.
Pageof 40

Showing results (381-390 of 393) with videos related to

Sort By:
Pageof 40
BMC Infectious Diseases|February 21, 2014
A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern TanzaniaElizabeth A Reddy, Boniface N Njau, Susan C Morpeth, et al.
The Journal of Infectious Diseases|June 22, 2022
Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative ChildrenColeen K Cunningham, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases|November 5, 2019
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn InfantsColeen K Cunningham, Elizabeth J McFarland, R Leavitt Morrison, et al.
Journal of the Pediatric Infectious Diseases Society|January 17, 2025
Safety, Tolerability, and Pharmacokinetics of Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC07-523LS in Newborn Infants Exposed to HIV-1Coleen K Cunningham, Elizabeth J McFarland, Petronella Muresan, et al.
The ISME Journal|September 13, 2021
Non-diphtheriae Corynebacterium species are associated with decreased risk of pneumococcal colonization during infancyMatthew S Kelly, Catherine Plunkett, Yahe Yu, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 13, 2022
Academic Health Centers and Humanitarian Crises: One Health System's Response to Unaccompanied Children at the BorderSherin U Devaskar, Coleen K Cunningham, Robin H Steinhorn, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling studyChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Plos One|March 19, 2025
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdensChristopher Alba, Shelly Malhotra, Stephanie Horsfall, et al.
Journal of the Pediatric Infectious Diseases Society|August 26, 2020
A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in ChildrenAndi L Shane, Alice I Sato, Carol Kao, et al.
The Journal of Infectious Diseases|August 30, 2014
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responsesGenevieve G Fouda, Coleen K Cunningham, Elizabeth J McFarland, et al.
Pageof 40